WWTR1

WWTR1
Identifiers
AliasesWWTR1, TAZ, WW domain containing transcription regulator 1
External IDsOMIM: 607392; MGI: 1917649; HomoloGene: 9159; GeneCards: WWTR1; OMA:WWTR1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001168278
NM_001168280
NM_015472
NM_001348362

NM_001168281
NM_133784

RefSeq (protein)

NP_001161750
NP_001161752
NP_056287
NP_001335291

NP_001161753
NP_598545

Location (UCSC)Chr 3: 149.52 – 149.74 MbChr 3: 57.36 – 57.48 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

WW domain-containing transcription regulator protein 1 (WWTR1[5]), also known as Transcriptional coactivator with PDZ-binding motif (TAZ), is a protein that in humans is encoded by the WWTR1 gene. WWTR1 acts as a transcriptional coregulator and has no effect on transcription alone.[5] When in complex with transcription factor binding partners, WWTR1 helps promote gene expression in pathways associated with development, cell growth and survival, and inhibiting apoptosis.[6] Aberrant WWTR1 function has been implicated for its role in driving cancers.[7][8][9] WWTR1 is often referred to as TAZ due to its initial characterization with the name TAZ. However, WWTR1 (TAZ) is not to be confused with the protein tafazzin, which originally held the official gene symbol TAZ, and is now TAFAZZIN.

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000018408Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000027803Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, et al. (December 2000). "TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins". The EMBO Journal. 19 (24): 6778–6791. doi:10.1093/emboj/19.24.6778. PMC 305881. PMID 11118213.
  6. ^ Hong W, Guan KL (September 2012). "The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway". Seminars in Cell & Developmental Biology. 23 (7): 785–793. doi:10.1016/j.semcdb.2012.05.004. PMC 3459069. PMID 22659496.
  7. ^ Moroishi T, Hansen CG, Guan KL (February 2015). "The emerging roles of YAP and TAZ in cancer". Nature Reviews. Cancer. 15 (2): 73–79. doi:10.1038/nrc3876. PMC 4562315. PMID 25592648.
  8. ^ Cite error: The named reference Zhang_2018 was invoked but never defined (see the help page).
  9. ^ Cite error: The named reference Zanconato_2016 was invoked but never defined (see the help page).